PubRank

Persephone Borrow

Author PubWeight™ 108.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009 6.22
2 The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2009 5.99
3 Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol 2005 5.83
4 Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003 5.36
5 Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009 4.98
6 Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003 4.60
7 Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 2004 3.48
8 Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 2010 3.02
9 Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 2013 2.75
10 Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002 2.59
11 Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010 2.39
12 Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007 2.32
13 Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest 2012 2.05
14 Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2011 1.74
15 HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol 2006 1.64
16 HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. J Clin Invest 2012 1.63
17 Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005 1.62
18 Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 2011 1.62
19 Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201. J Med Chem 2005 1.62
20 Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. J Virol 2011 1.57
21 Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 2013 1.55
22 Development of the antibody response in acute HIV-1 infection. AIDS 2004 1.54
23 HIV-1 Populations in Semen Arise through Multiple Mechanisms. PLoS Pathog 2010 1.47
24 Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 2011 1.44
25 Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog 2011 1.42
26 Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN. J Immunol 2005 1.38
27 Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol 2009 1.37
28 Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One 2011 1.32
29 Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol 2005 1.31
30 Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J Virol 2010 1.26
31 Expression of the beta-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J Leukoc Biol 2004 1.26
32 Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice. J Immunol 2009 1.23
33 Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J Virol 2011 1.21
34 Defective B cell responses in the absence of SH2D1A. Proc Natl Acad Sci U S A 2005 1.21
35 Polyinosinic acid is a ligand for toll-like receptor 3. J Biol Chem 2007 1.19
36 Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog 2010 1.16
37 Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection. AIDS 2004 1.14
38 Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol 2007 1.14
39 Towards the chemometric dissection of peptide--HLA-A*0201 binding affinity: comparison of local and global QSAR models. J Comput Aided Mol Des 2005 1.11
40 Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth. PLoS Pathog 2013 1.05
41 Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. Blood 2012 1.02
42 Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J Virol 2012 1.02
43 Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J Immunol 2003 0.99
44 Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection. J Immunol 2012 0.98
45 Coupling in silico and in vitro analysis of peptide-MHC binding: a bioinformatic approach enabling prediction of superbinding peptides and anchorless epitopes. J Immunol 2004 0.97
46 Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-gamma in the absence of interleukin-12. Eur J Immunol 2003 0.95
47 Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection. J Gen Virol 2005 0.95
48 Reciprocal immunomodulation in a schistosome and hepatotropic virus coinfection model. J Immunol 2005 0.95
49 Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy. J Immunol 2007 0.90
50 Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. Eur J Immunol 2010 0.86
51 Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res Hum Retroviruses 2014 0.85
52 Influenza H2 haemagglutinin activates B cells via a MyD88-dependent pathway. Eur J Immunol 2006 0.83
53 Computational vaccinology: quantitative approaches. Novartis Found Symp 2003 0.83
54 Epitope specificity and relative clonal abundance do not affect CD8 differentiation patterns during lymphocytic choriomeningitis virus infection. J Virol 2009 0.83
55 Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes. PLoS One 2009 0.83
56 Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice. Int Immunol 2004 0.82
57 A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming. Eur J Immunol 2006 0.82
58 Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. J Gen Virol 2005 0.80
59 Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption. AIDS 2009 0.80
60 CD45 is required for type I IFN production by dendritic cells. Eur J Immunol 2006 0.80
61 The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk. PLoS One 2011 0.79
62 Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals. Vaccine 2008 0.78
63 Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection. Eur J Immunol 2013 0.76
64 Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection. Retrovirology 2011 0.76
65 Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honoured. Retrovirology 2013 0.75
66 Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. bioRxiv 2020 0.75
67 Obituary: Kuan-Teh Jeang. Retrovirology 2013 0.75
68 Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide. Viral Immunol 2002 0.75